Advertisement

89,592 bottles of Children's Ibuprofen Recalled

By The Banner News Team
From the Mar 24, 2026 e-Edition

89,592 bottles of children’s ibuprofen have been recalled after reports they contained a “foreign substance.” According to an FDA enforcement report, Strides Pharma Inc. recalled the medicine because the company received complaints of a “gel-like mass and black particles” in the product.

The recall affects 100-milligram Children’s Ibuprofen Oral Suspension, sold nationwide in a 4-fluid-ounce bottle. The lot numbers for the affected bottles are 7261973A and 7261974A, and the medication expires on Jan. 31, 2027, according to the FDA report. Consumers who have the recalled ibuprofen should stop using it immediately.

Recall Initiation Date: 3/2/2026

Center Classification Date: 3/16/2026

Classification: Class II

Product Quantity: 89592 bottles

Product Description: Children's Ibuprofen Oral Suspension, USP, 100 mg per 5mL, 4 FL OZ (120 mL) bottle, Manufactured for: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, Made in India, NDC 51672-5321-8.

Code Information: Lot: 7261973A, 7261974A, Expiration 01/31/2027

Reason for Recall: Presence of foreign substance: the firm received complaints for a gel-like mass and black particles in the product.

Voluntary / Mandated: Voluntary: Firm initiated

Recalling Firm: STRIDES PHARMA INC, 200 Crossing Blvd Ste 110, Bridgewater, NJ 08807-2861, United States

View the report: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=218947

Advertisement
McKenzie Banner March 24, 2026 + A Tribute to Women's History 2026

In the e-Edition

McKenzie Banner March 24, 2026 + A Tribute to Women's History 2026

Mar 24, 2026 · Read the full issue →

Related Stories

© Copyright 2026 Tri-County Publishing, Inc. | Privacy | Terms
Powered by Novel.ad